Matt Hoffman
banner
bymatthoffman.bsky.social
Matt Hoffman
@bymatthoffman.bsky.social
Editorial director: NeurologyLive | IJMSC | CGTLive | Contagion | Optometry Times | Ophthalmology Times | Modern Retina | OT Europe

Proud Rowan grad 🦉

Covering clinical care: linktr.ee/matthoff
Pinned
Hi! 👋 I'm new to BlueSky—I'm the editorial director for a long list of well-known specialty medical care brands, so if you're looking for clinically relevant news and information, our teams have you covered!

Head here to check out all of their coverage: linktr.ee/matthoff
Matt Hoffman | Linktree
Click below to get the news and insights for your specialty in medicine. 🩺💊
linktr.ee
A lot happened last month in the @cdcgov.govmirrors.com's latest ACIP vaccines meeting. Amid the debate, though, there was clinically relevant conversation. @contagionlive.bsky.social was on the case with coverage, and I did my best to summarize some of that here:
www.linkedin.com/pulse/naviga...
Navigating Clarity in a Cloudy Vaccine Landscape: ACIP’s September 2025 Decisions and What They Mean for Clinical Practice
In what perhaps came as no surprise, this month’s Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) meeting—taking place over the 2-day span of September 1...
www.linkedin.com
October 1, 2025 at 5:29 PM
Reposted by Matt Hoffman
🚨 Dr. Vinay Prasad resigns as the FDA’s CBER Director after months marked by tough gene therapy disputes & changes to #COVID19 vaccine policies. His cautious, evidence-based leadership sparked debate amid safety & political concern #IDsky #MEDsky

More details: www.contagionlive.com/view/fda-cbe...
FDA CBER Director Resigns Amid Gene Therapy Controversy and COVID-19 Vaccine Policy Changes
Vinay Prasad’s, MD, MPH, short tenure marked by tough regulatory decisions and political pushback; the Trump administration has not yet named a successor for the CBER director role.
www.contagionlive.com
July 30, 2025 at 3:24 PM
Reposted by Matt Hoffman
Multiple sclerosis isn’t just relapses and mobility issues. Fatigue, cognitive dysfunction, and emotional well-being matter too.

Dr. Taylor Hess breaks it all down in our latest episode for #WorldMSDay 🎙️
➡️ www.neurologylive.com/view/episode...
Episode 142: World MS Day: Raising Awareness, Evolving Care, and Empowering Patients
Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Taylor Hess, MD. [LISTEN TIME: 10 minutes]
www.neurologylive.com
May 30, 2025 at 12:33 PM
Reposted by Matt Hoffman
So many opportunities to learn and network at #CMSC2025. Where will we see you? And this year is especially poignant as we remember June Halper, a Giant of #MS, and a woman who devoted herself to the #CMSC community.
May 28, 2025 at 5:50 PM
Reposted by Matt Hoffman
The FDA has granted Fast Track Designation to ARCT-2304, an investigational sa-mRNA vaccine from Arcturus Therapeutics aimed at protecting against #H5N1 influenza, accelerating its development. #birdflu #avianinfluenza #IDsky #MEDsky

Read here: www.contagionlive.com/view/fda-gra...
FDA Grants Fast Track Status to ARCT-2304 for H5N1 Influenza Protection
Investigational sa-mRNA vaccine advances to phase 1 trials for pandemic preparedness
www.contagionlive.com
April 10, 2025 at 1:34 PM
Ep 3 of @cgtlive.bsky.social's #ImmunoLogic podcast with Joseph Fraietta, PhD, and Janna Minehart, MD, is now live! Our guest is Marcela Maus, MD, PhD, of @massgeneralbrigham.bsky.social to talk about her research into the use of #CART therapy to treat #glioblastoma.
www.cgtlive.com/view/immunol...
ImmunoLogic, Episode 3: "Breaking the Brain’s Barrier: CAR T-Cells Take on Glioblastoma" With Marcela Maus, MD, PhD
In Episode 3 of ImmunoLogic, Marcela Maus, MD, PhD, discussed her research on CAR-T for treating glioblastoma.
www.cgtlive.com
April 8, 2025 at 7:17 PM
Reposted by Matt Hoffman
"Exposure to a dedicated young-adult #virtual support group may provide a sense of normalcy, belonging, and validation and may give #YoungAdults the opportunity to interact and communicate with #peers living with" #MultipleSclerosis.
doi.org/10.7224/1537...
April 7, 2025 at 7:08 PM
Reposted by Matt Hoffman
Last Friday, we launched the latest episode of our Mind Moments podcast, featuring expert insight from special guest @danharrisonmd.bsky.social! In this 20-min convo, we discuss everything regarding NP education, including the changing roles of NPs:

Listen in 🎙️ www.neurologylive.com/view/episode...
April 7, 2025 at 3:29 PM
Reposted by Matt Hoffman
A child who was not vaccinated succumbed to #measles pulmonary failure. Additionally, increased cases and hospitalizations continue to grow greatly in the state. #IDsky #medsky
Second Measles Death In Texas
A child who was not vaccinated succumbed to measles pulmonary failure. Additionally, increased cases and hospitalizations continue to grow greatly in the state.
www.contagionlive.com
April 7, 2025 at 2:29 PM
Reposted by Matt Hoffman
We launched our interactive Spring 2025 Issue. Come check it out! #IDsky #Medsky

Read the issue here: www.contagionlive.com/publications...
April 4, 2025 at 6:21 PM
Reposted by Matt Hoffman
ICYMI: Dr. Moupali Das presented data at #CROI2025 showing Gilead's once-yearly Lenacapavir formulations for HIV PrEP sustain efficacy for 56 weeks. This phase 1 study paves the way for improved adherence & HIV prevention. #IDsky #HIVsky #MEDsky

Learn more: www.contagionlive.com/view/gilead-...
March 19, 2025 at 3:59 PM
There were ~several~ clinical care guidelines that were updated in 2024, shaping the way physicians diagnose and treat. The @neurologylive.bsky.social team put together a wonderful overview of all of those changes, in a single resource:
www.neurologylive.com/view/bluepri...
Blueprints for Better Care: 2024 Neurology Guideline Highlights
Explore the key 2024 neurology guideline updates shaping clinical care across stroke, epilepsy, movement disorders, and more in this essential feature.
www.neurologylive.com
March 12, 2025 at 4:11 PM
Episode 2 of @cgtlive.bsky.social's podcast, #ImmunoLogic, is here!! 🎙️ Joseph Fraietta, PhD, and Janna Minehart, MD, spoke with Bruce Levine, PhD, to explore the @fda.gov’s black box warnings in CAR-T therapy and the NIH's role in advancing #CART research, among other topics.

Check it out here:
ImmunoLogic, Episode 2: "Charting New Frontiers in CAR T-Cell Safety" With Bruce Levine, PhD
In Episode 2 of ImmunoLogic, Bruce Levine, PhD, discussed the current the risk-benefit-ratio for CAR-T therapy.
www.cgtlive.com
March 11, 2025 at 8:45 PM
Reposted by Matt Hoffman
New Mexico resident has died after testing positive for #Measles, though the official cause of death is still under investigation. They were unvaccinated & did not seek medical care prior to passing. The NMDOH urges residents to get vaccinated. #IDsky #MEDsky

www.contagionlive.com/view/measles...
Measles-Positive New Mexico Resident Dies, Cause of Death Still Unconfirmed
The official cause of death is still under investigation by the New Mexico Office of the Medical Investigator, though the individual tested positive for the measles virus.
www.contagionlive.com
March 7, 2025 at 2:18 PM
Reposted by Matt Hoffman
ICYMI: Dr. Manjot Gill from @NorthwesternMed Medicine discusses how a study on retinal capillary perfusion in #LongCOVID patients may provide valuable insights into the neuro effects of the condition & offer markers for diagnosis & treatment. #IDsky #MEDsky

www.contagionlive.com/view/retinal...
March 6, 2025 at 5:14 PM
Reposted by Matt Hoffman
See you in San Francisco at #CROI2025 🌉🏙️

Contagion will be at CROI March 9-12— we are excited to connect with you and share your research! #IDsky #MEDsky
February 28, 2025 at 2:33 PM
Did you know: 2025 marks the 50th(!!!) year of Ophthalmology Times?

At the American Glaucoma Society meeting, we heard from John Berdahl, MD; Inder Paul Singh, MD; and Shan Lin, MD on just how much has changed in those 5 decades. #AGS2025
www.ophthalmologytimes.com/view/50-year...
50 Years in Ophthalmology: A look at glaucoma treatments
We asked ophthalmologists what stands out to them in the history of treating glaucoma and where future treatments might be heading.
www.ophthalmologytimes.com
February 28, 2025 at 4:45 PM
For #RareDiseaseDay, @neurologylive.bsky.social had a few recent conversations worth reading:

Amber Freed, on her journey and advocacy efforts: www.neurologylive.com/view/rare-di...

Mary Schroth, MD, on the efforts in SMA:
www.neurologylive.com/view/rare-di...
Rare Disease Day 2025: Transforming Challenges Into Action for SLC6A1
Amber Freed, founder of SLC6A1 Connect, shared her personal journey and advocacy efforts to raise awareness for SLC6A1, a rare genetic epilepsy, in honor of Rare Disease Day.
www.neurologylive.com
February 28, 2025 at 4:19 PM
The @neurologylive.bsky.social team is on site at the #actrims2025 forum in West Palm Beach!

Follow along here for all of the coverage, interviews, and updates:
www.neurologylive.com/conferences/...
February 27, 2025 at 10:25 PM
Reposted by Matt Hoffman
The state’s health department has confirmed all 3 cases are in people who are unvaccinated. #measles #IDsky #Medsky
3 Case of Measles Reported in New Jersey
The state’s health department has confirmed all 3 cases are in people who are unvaccinated.
www.contagionlive.com
February 27, 2025 at 8:34 PM
From @contagionlive.bsky.social: A school-aged child has died from #measles in Texas—the first death in the ongoing outbreak, which now has 124 cases. CHOP's Paul Offit, MD, warns that such outbreaks signal declining childhood vaccination rates.

Learn more:
www.contagionlive.com/view/measles...
Measles: The Canary in the Coal Mine for Childhood Vaccine Decline
On the heels of the first death in an ongoing US-based measles outbreak, Paul Offit, MD, discusses how outbreaks are the first sign that childhood vaccination rates are starting to decline.
www.contagionlive.com
February 27, 2025 at 12:14 AM
The #Ophthalmology Times team is still cranking out interview content from last weekend's #EnVisionSummit (which you can find on our website).

If you're looking for some immediate takeaways from the interviews we've already posted, I've got you covered here:
www.linkedin.com/pulse/envisi...
Envision Summit 2025: Insights and Takeaways
Last weekend, Envision Summit 2025 brought together ophthalmologists, optometrists, and eye care specialists in San Juan, Puerto Rico, to participate in discussions on the recent advancements in clini...
www.linkedin.com
February 19, 2025 at 7:06 PM
AI can reshape scientific publishing, from manuscripts to peer review—but challenges around authorship, transparency, and integrity remain. How do we navigate its role while maintaining ethical standards?

#ArtificialIntelligence #ScientificPublishing
www.linkedin.com/pulse/balanc...
A Balancing Act: AI and Scientific Publishing
Over the past 18 months, we've all had at least one conversation with a colleague or a peer about artificial intelligence (AI). Whether about OpenAI's ChatGPT or Micosoft's Copilot—or one of the hundr...
www.linkedin.com
February 14, 2025 at 10:12 PM
The KDHE reported the largest #tuberculosis outbreak in US history, centered in Wyandotte and Johnson Counties, near Kansas City.

As of Jan 24:
🔹 Active – Wyandotte: 60; Johnson: 7
🔹 Latent – Wyandotte: 77; Johnson: 2

Read more from @contagionlive.bsky.social:
www.contagionlive.com/view/state-o...
State of Kansas Reports Country’s Largest Tuberculosis Outbreak
The outbreak is currently concentrated in 2 counties in the state, Wyandotte and Johnson.
www.contagionlive.com
January 28, 2025 at 6:28 PM